Fri, Jul 25, 2014, 1:18 PM EDT - U.S. Markets close in 2 hrs 42 mins


% | $
Click the to save as a favorite.

Exelixis, Inc. Message Board

  • stocklooking stocklooking Mar 8, 2013 2:31 PM Flag

    How to contact BOD?

    It's only one month to annual meeting. How can we vent our resentment to BOD? If we all complain about CEO/CFO, will they listen? Sending email to IR will get into CFO or CEO's hands?
    Stelios Papadopoulos
    Charles Cohen
    Carl B. Feldbaum
    How can we send emails to them directly?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • emailing ir is worthless as he is.i would also like to get in touch with BOD if find out how start new post

    • How many contractions and possessive apostrophes do you think a Chinese guy with terrible broken English uses?


      And the incomprehensible inconsistent use of articles!?!?!

      You are, as you say, 'in-creditable'!!

    • $$$$

      "If we all complain about CEO/CFO, will they listen?"

      Doubtful. The current management team has produced the first approved drug in EXEL history. In addition, the pathway to further label expansion is well under construction. I expect if the BOD were displeased w/ their senior management team, they would do something about it other than approve raises and bonuses for them.



      Hey, Elmer (aka onthejobsj, konasurfs1, bushido, stockmaven888, mining_phd, and your favorite nomad_dumba55), how's the new ID working out for ya?

      Is working good out? Happy? Early up you for now, yes?

      I personally don't want to see the shorts begin to cover now.

      Much better at $7, $10, $13...

      RELAXXXXX, you got all the time in the world.....

      .......just relaxxxxxxxxx

4.18-0.03(-0.83%)1:17 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.